VEGFD and breast benign neoplasm: In divided control group (into benign breast tumor and healthy women group), we observed statistical significance when compared plasma levels of VEGF-A, VEGF-C and CA 15–3 with benign breast tumor and when compared VEGF-A, VEGF-C, VEGF-D and CA 15–3 with healthy women group.